A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Background. Respiratory syncytial virus (RSV) is a leading cause of childhood bronchiolitis and pneumonia, particularly in early infancy. Immunization of pregnant women could boost preexisting immune responses, providing passive protection to newborns through placental transfer of anti-RSV antibody....

Descripción completa

Detalles Bibliográficos
Autores principales: Langley, Joanne M., Aggarwal, Naresh, Toma, Azhar, Halperin, Scott A., McNeil, Shelly A., Fissette, Laurence, Dewé, Walthere, Leyssen, Maarten, Toussaint, Jean-François, Dieussaert, Ilse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225248/
https://www.ncbi.nlm.nih.gov/pubmed/27694633
http://dx.doi.org/10.1093/infdis/jiw453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225248/
https://www.ncbi.nlm.nih.gov/pubmed/27694633
http://dx.doi.org/10.1093/infdis/jiw453

Ejemplares similares